2021 IPO

EQRx Stock

EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery.

Sign up today and learn more about EQRx Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About EQRx Stock

EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. EQRx was founded in 2019 and is based in Cambridge, Massachusetts, United States.

Funding History

January 2020$200M

Management

Co-Founder

Peter Bach

Co-Founder

Sandra Horning

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo